Focus:
Deal News
-
11 October 2019
Bayer and Sensyne Health team up for AI-enabled imaging
Bayer has partnered with UK-based clinical artificial intelligence (AI) technology company Sensyne Health to create AI-enabled radiology and imaging solutions.
-
9 October 2019
Qiagen and Illumina sign 15-year deal for IVD tests
Diagnostic solutions providers Qiagen and Illumina have collaborated to boost the availability and use of next-generation sequencing (NGS)-based in-vitro diagnostic (IVD) tests, including companion diagnostics, for clinical patient management.
-
9 October 2019
GE Healthcare partners with Theragnostics for prostate cancer
GE Healthcare has formed a global alliance with Theragnostics for the commercialisation of a prostate-specific membrane antigen (PSMA) PET / CT imaging agent, GalliProst.
-
3 October 2019
Hydrix to provide AngelMed Guardian System in Australia
Technology company Hydrix has partnered with medical device developer Angel Medical Systems (AngelMed) for exclusive rights to distribute a heart attack alerting device in Australia.
-
3 October 2019
AngioDynamics buys PAD laser technology firm Eximo Medical
AngioDynamics has acquired medical device firm Eximo Medical and its laser technology for the treatment of peripheral artery disease (PAD).
-
26 September 2019
Eko secures funds to develop AI tool for cardiac screening
Digital health firm Eko has closed a Series B funding round to support the development of an artificial intelligence (AI)-based solution for cardiac screening and analysis.
-
24 September 2019
Guerbet and IBM Watson to develop AI-based prostate cancer detection
Medical imaging solutions firm Guerbet has partnered with IBM Watson Health to develop and commercialise an artificial intelligence (AI)-based solution to diagnose prostate cancer.
-
19 September 2019
Adaptive to provide clonoSEQ MRD test for Amgen drug development
Adaptive Biotechnologies has signed a worldwide agreement to provide its clonoSEQ minimal residual disease (MRD) test for Amgen’s haematological drug development.
-
18 September 2019
Kaia Health nets $8m in latest funding round
Digital therapeutics company Kaia Health has announced the closure of an $8m funding round led by healthcare venture capital firm Optum Ventures.
-
18 September 2019
Happify Health forms digital therapeutics alliance with Sanofi
Happify Health, a provider of mental health technology and digital therapeutics, has partnered with pharmaceutical giant Sanofi to offer prescription digital therapeutics for improving the mental health of multiple sclerosis...
Close
Close
Close
Go Top
